Adverum Biotechnologies, Inc. 3 SEC Filings

Filed On	Filing
05 Dec 2025	Form 3: Frazier Life Sciences Public Fund, L.p., 10% owner and 2 others Holds 4,288,949 shares of Common Stock
18 Jul 2024	Form 3: Leonard Braden Michael, 10% owner Holds 2,103,176 shares of Common Stock
20 Jun 2024	Form 3: Kiss Szilard, Director
06 Nov 2023	Form 3: Nicholson, C. David, Director Holds 0 shares of No securities owned.
15 Dec 2022	Form 3: Rubinstein Linda M, Chief Financial Officer Holds 0 shares of No securities are beneficially owned.
10 Jun 2022	Form 3: Rakow John, SVP, Genl Counsel, Acting CFO Holds 58,233 shares of Common Stock
07 Jun 2022	Form 3: Pecota Nancy E, Principal Accounting Officer Holds 0 shares of No securities owned
18 Mar 2022	Form 3: Hong Soo, Director Holds 0 shares of No securities owned.
18 Mar 2022	Form 3: Ozden Rabia Gurses, Director Holds 0 shares of No securities owned.
09 Feb 2022	Form 3: Beckman Richard, Chief Medical Officer Holds 0 shares of No securities owned.
10 Jan 2022	Form 3: Seyedkazemi Setareh, Chief Development Officer Holds 600 shares of Common Stock
08 Dec 2021	Form 3: D'Souza Rupert, Chief Financial Officer Holds 850 shares of Common Stock
14 Sep 2021	Form 3: Riley Brigit, Chief Scientific Officer Holds 120,000 shares of Common Stock
13 Sep 2021	Form 3: Thrift Jack Anthony, Interim CFO Holds 0 shares of No securities owned.
29 Jun 2021	Form 3: DeRespino Christopher, See Remarks
03 Jun 2021	Form 3: Clark Julie, Chief Medical Officer Holds 49,489 shares of Common Stock
23 Feb 2021	Form 3: Tuckson Reed Vaughn, Director Holds 0 shares of No securities owned.
11 Dec 2020	Form 3: Svoronos Dawn, Director Holds 0 shares of No Securities Owned
17 Jun 2020	Form 3: Fischer Laurent, Director Holds 0 shares of No securities owned.
20 Apr 2020	Form 3: Whitcup Scott M, Director Holds 0 shares of No securities owned.

Comments